Goodsurance

Enrollment & timing

Part D Plans Face Back-to-Back Deadlines This Week to Finalize 2027 Premiums and Market Participation

Medicare prescription drug plans must complete rebate reallocation by August 6 and notify CMS of de minimis intent by August 11, two steps that lock in whether plans remain in the 2027 market and at what premium.

By the Goodsurance editorial teamAugust 5, 2026

Medicare Part D plan sponsors face two consecutive deadlines this week that will shape the drug coverage options and premiums beneficiaries see in 2027. The first deadline is Thursday, August 6, 2026, when plans must finish rebate reallocation, the process by which Medicare Advantage prescription drug plans apply government-held rebate dollars to reduce member drug premiums, by 11:59 PM Pacific time. CMS laid out that timeline in a July 28, 2026 announcement to plan sponsors. After reallocation closes, sponsors have a brief additional window, from August 7 through 11:59 PM Pacific on August 11, 2026, to tell CMS whether they intend to invoke the de minimis provision. That provision allows a plan with a net drug premium at or below zero after reallocation to remain in the market, with CMS negotiating the premium back to zero. Plans that miss the August 11 notification deadline cannot use de minimis and may need to exit the 2027 market. These mechanics follow the July 28 announcement that the Part D national average monthly bid amount for 2027 is 296 dollars and 5 cents and that the base beneficiary premium for 2027 is 41 dollars and 33 cents. Beneficiaries will not see their specific 2027 plan options or premiums until the Annual Notice of Change period that precedes the fall open-enrollment window.

In plain words

Medicare drug plans had two important deadlines this week. By August 6, plans had to finish moving rebate money to lower the cost of drug coverage for members. Then, by August 11, plans had to tell Medicare if they wanted to stay in the program even if their drug premium came out at zero or less. These steps help decide which drug plans will be available in 2027 and how much they will cost. The average base drug premium for 2027 is set at 41 dollars and 33 cents.

Source: CMS
Read at the source →

More news

Other stories on what is moving in Medicare.

Enrollment & timing

Drug Plans Have Until August 11 to Waive a Small Premium Gap That Could Keep Low-Income Members Enrolled

With today marking the close of the 2027 Part D rebate reallocation window, a five-day period opens Friday for sponsors to declare they will absorb a premium difference of up to 2 dollars rather than trigger automatic reassignment for their Extra Help members.

August 6, 2026

Enrollment & timing

KFF: Nine in Ten Medicare Advantage Enrollees Ages 65 and Older Have No Federal Guarantee They Can Buy Medigap if They Switch Back to Original Medicare

A KFF issue brief finds that medical underwriting rules block most Medicare Advantage enrollees from accessing Medigap supplemental coverage if they later want the broader provider access of original Medicare, a gap that grows more consequential as plan exits accelerate heading into 2027.

August 3, 2026

Enrollment & timing

Part D Benchmark Rises Nearly 24 Percent for 2027. CMS Expects Zero-Premium Plans to Remain Available for Low-Income Enrollees.

The July 28 bid-data release set the 2027 Part D national average bid at 296 dollars and 5 cents, raising the stakes for 13.6 million enrollees who rely on premium-free drug coverage through the Extra Help program.

August 2, 2026

Enrollment & timing

Minnesota Residents Ages 65 to 70 Gain an Annual Window to Buy Medigap Without Health Screening

A state law creating recurring guaranteed-issue periods for Medigap took effect today in Minnesota, adding the state to a short list of jurisdictions that limit medical underwriting for Medicare supplement policies.

August 1, 2026

Enrollment & timing

Two Different Letters Are Coming to Medicare Advantage Members This Fall. Here Is What Each One Means.

By September 30, every continuing Medicare Advantage plan must notify members of what is changing for 2027. Members whose plan is leaving their area receive a separate letter with different choices and deadlines.

July 31, 2026

Enrollment & timing

The July 28 Bid Release Starts the Clock on the Most Consequential Medicare Open Enrollment in Years

Plan sponsors must finalize 2027 bids by August 6. Members get written notice of changes by September 30. Open enrollment runs October 15 through December 7, and this year drug plan prices and insurer footprints are both in flux.

July 28, 2026